• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.73 Up 0.09(2.47%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.64
    Open:3.65
    Bid:3.37 x 300
    Ask:4.44 x 500
    1y Target Est:8.71
    Beta:4.14
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:3.65 - 3.75
    52wk Range:3.22 - 5.95
    Volume:1,876,798
    Avg Vol (3m):2,490,090
    Market Cap:433.37M
    P/E (ttm):N/A
    EPS (ttm):-0.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    XOMAUp 2.47%433.37M
    NVSUp 0.91%243.00B
    REGNUp 1.16%46.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):22.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.59
    Quarterly EPS Est (Mar-15) :-0.16
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.32

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback